Can-Fite BioPharma Ltd. (CANF)
Quantitative Summary
DeterministicBelow-average fundamentals indicated by Piotroski score of 2/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
ETF Contagion Visualizer
Simulate a price drop in Can-Fite BioPharma Ltd. to visualize passive redemption contagion across ETFs and collateral stocks.
If Can-Fite BioPharma Ltd. (CANF) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies TENCENT HOLDINGS LTD (700) as the most exposed collateral stock, sharing 1 ETFs with CANF. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
CANF Ownership Dynamics
ETFs with Highest CANF Exposure
Float lock-up computed from 2 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 1,504 | $3.39 | $5,098.56 |
| 2026-05-12 | 5,628 | $3.36 | $18,910.08 |
| 2026-05-11 | 4,187 | $3.51 | $14,696.37 |
| 2026-05-08 | 11,211 | $3.54 | $39,686.94 |
| 2026-05-07 | 45,855 | $3.35 | $153,614.25 |
| 2026-05-06 | 53,063 | $3.50 | $185,720.5 |
| 2026-05-05 | 216,615 | $3.32 | $719,161.8 |
| 2026-05-04 | 333,865 | $2.93 | $978,224.45 |
| 2026-05-01 | 408,655 | $3.19 | $1.3M |
| 2026-04-28 | 2,182 | $2.92 | $6,371.44 |
| 2026-04-27 | 2,375 | $2.91 | $6,911.25 |
| 2026-04-22 | 2,460 | $2.92 | $7,183.2 |
| 2026-04-16 | 1,012 | $3.17 | $3,208.04 |
| 2026-04-09 | 98 | $3.08 | $301.84 |
| 2026-04-02 | 100 | $3.09 | $309 |
| 2026-03-10 | 2 | $4.08 | $8.16 |
| 2026-03-09 | 3 | $4.55 | $13.65 |
| 2026-03-06 | 143 | $4.60 | $657.8 |
| 2026-03-05 | 73,976 | $6.02 | $445,335.52 |
| 2026-03-04 | 59 | $5.00 | $295 |
| 2026-03-02 | 280 | $4.75 | $1,330 |
| 2026-02-27 | 306 | $4.93 | $1,508.58 |
| 2026-02-26 | 999 | $4.59 | $4,585.41 |
| 2026-02-24 | 3,468 | $4.56 | $15,814.08 |
| 2026-02-23 | 5,110 | $4.65 | $23,761.5 |
| 2026-02-20 | 1,326 | $4.44 | $5,887.44 |
| 2026-02-19 | 428 | $4.31 | $1,844.68 |
| 2026-02-18 | 591 | $4.41 | $2,606.31 |
| 2026-02-17 | 2,601 | $4.53 | $11,782.53 |
| 2026-02-13 | 641 | $4.32 | $2,769.12 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare CANF to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.